Evidence map›Paper›PMID 34812730›Full record

ReviewCanadian Urological Association journal = Journal de l'Association des urologues du Canada2022

Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context.

Michael P Kolinsky, Karen Y Niederhoffer, Edmond M Kwan, Sebastien J Hotte, Zineb Hamilou, Steven M Yip, Kim N Chi, Alexander W Wyatt, Fred Saad

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional survey.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Michael P KolinskyCross Cancer Institute, Edmonton, Alberta, Canada; Department of Oncology, University of Alberta, Edmonton, AB, Canada.
Karen Y NiederhofferDepartment of Medical Genetics, University of Alberta, Edmonton, AB, Canada.
Edmond M KwanVancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Sebastien J HotteDepartment of Oncology, McMaster University, Hamilton, ON, Canada.
Zineb HamilouDivision of Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Steven M YipTom Baker Cancer Centre and Cumming School of Medicine, Calgary, AB, Canada.
Kim N ChiBC Cancer Agency and University of British Columbia, Vancouver, BC, Canada.
Alexander W WyattVancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia and Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
Fred SaadCentre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada.
Centre Hospitalier de l’Université de Montréal · CAUniversity of Alberta · CAUniversity of British Columbia · CACanada's Michael Smith Genome Sciences Centre · CAMcMaster University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34812730
PMCPMC9054340
OpenAlexW3217809703

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.